Gennao Bio
Dr. Peter Glazer is chair of the department of therapeutic radiology, professor of genetics, and the Robert E. Hunter professor of therapeutic radiology at the Yale School of Medicine. His research focuses on elucidating pathways of DNA repair in cancer and developing novel agents for cancer therapy and for gene therapy. In addition to Gennao Bio, Dr. Glazer is a co-founder of Cybrexa Therapeutics. He earned a B.A. in Chemistry from Harvard, M.S. in Biochemistry from the University of Oxford, and M.D. and Ph.D. in Genetics from Yale.
This person is not in the org chart
This person is not in any offices
Gennao Bio
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.